Skip to content

000503.SZ

国新健康

SZSE · Healthcare · I 信息技术 · CN

CNY 6.70
−2.47%
Ask drillr

Year over year

Reported trailing growth

Revenue
-2.5%
EBITDA
EBIT
EPS
Free cash flow
-43.3%
Operating cash flow
-74.3%

Forward estimates

Based on analyst estimates

Revenue
EBITDA
EPS

Three-year CAGR

Revenue
+4.1%
EBITDA
EBIT
Net income
EPS
Free cash flow
-6.0%

Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026